Adaptive Biotechnologies
Kevin Tsai is a Senior Research Scientist at Adaptive Biotechnologies Corp. since June 2021, following a progression from Research Scientist to Scientist 3 and 2 at Thermo Fisher Scientific from August 2015 to May 2021. Kevin's career began with roles such as Research Associate 2 at Affymetrix and Laboratory Technician at Agilent Technologies in July 2015. Prior experience includes working as a Scientific Recruiter at R&D Partners, Research Assistant at Affymetrix, and Clinical Associate at MedImmune. Kevin's early roles included positions at Big 5 Sporting Goods and Costco Wholesale. Kevin holds a Bachelor of Science in Cell/Cellular and Molecular Biology from California Polytechnic State University-San Luis Obispo, obtained in 2012.
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.